Understand the source comparison
Use Peptides for Inflammation: Peptide Class Comparison
BPC-157 VEGF upregulation, growth factor receptor activation Angiogenesis, tissue repair 200–500 mcg per dose (animal models) Wound healing, gut inflammation, tendon repair Gold standard for angiogenesis-driven repair. Most published data Thymosin Beta-4 Actin
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- BPC-157
- VEGF upregulation, growth factor receptor activation
- Angiogenesis, tissue repair
- 200–500 mcg per dose (animal models)
- Wound healing, gut inflammation, tendon repair
- Gold standard for angiogenesis-driven repair. Most published data
- Thymosin Beta-4
- Actin polymerisation modulation, cytokine regulation
- Toll-like receptor pathways, immune modulation
- 5–20 mg depending on model
- Cardiac inflammation, muscle injury, corneal repair
- Robust clinical data but higher cost per dose
- KPV Tripeptide
- NF-κB translocation inhibition
- Pro-inflammatory gene transcription
- 1–10 µM (cell culture), 1–5 mg (in vivo)
- IBD models, dermatitis, autoimmune conditions
- Highly specific NF-κB inhibitor. Narrow but potent application
- Thymalin
- Thymic peptide complex immune regulation
- T-cell differentiation, cytokine balance
- 5–10 mg per dose
- Immune senescence, chronic inflammation, autoimmune research
- Underutilised in US research despite strong Eastern European data